Theriva Biologics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $16.3M | $35.4M | $11.6M |
| FY2025 | $22.9M | $38.2M | $13.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $16.3M | $35.4M | $11.6M |
| FY2025 | $22.9M | $38.2M | $13.1M |